National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical issues for biomarkers of heart failure

被引：68

作者：

Apple, Fred S. ^{[1
]}

Wu, Alan H. B.

Jaffe, Allan S.

Panteghini, Mauro

Christenson, Robert H.

Apple, Fred S. ^{[1
]}

Cannon, Christopher P.

Francis, Gary

Jesse, Robert L.

Morrow, David A.

Newby, L. Kristen

Storrow, Alan B.

Tang, W. H. Wilson

Wu, Alan H. B.

Apple, Fred S. ^{[1
]}

Christenson, Robert H.

Jaffe, Allan S.

Pagani, Franca

Tate, Jillian

Ordonez-Llanos, Jordi

Mair, Johannes

机构：

[1] Hennepin Cty Med Ctr, Minneapolis, MN USA

[2] Univ Calif San Francisco, San Francisco, CA 94143 USA

[3] Mayo Clin, Rochester, MN USA

[4] Univ Milan, I-20122 Milan, Italy

[5] Univ Maryland, Sch Med, Baltimore, MD 21201 USA

来源：

CIRCULATION | 2007年 / 116卷 / 05期

关键词：

D O I：

10.1161/CIRCULATIONAHA.107.185266

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：E95 / E98

页数：4

共 30 条

[1]

[Anonymous], AHRQ PUBLICATION

[2] Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death [J].

Apple, FS ;

Murakami, MM ;

Pearce, LA ;

Herzog, CA .

CLINICAL CHEMISTRY, 2004, 50 (12) :2279-2285

[3] Quality specifications for B-type natriuretic peptide assays [J].

Apple, FS ;

Panteghini, M ;

Ravkilde, J ;

Mair, J ;

Wu, AHB ;

Tate, J ;

Pagani, F ;

Christenson, RH ;

Jaffe, AS .

CLINICAL CHEMISTRY, 2005, 51 (03) :486-493

[4] The effect of class-specific protease inhibitors on the stabilization of B-type natriuretic peptide in human plasma [J].

Belenky, A ;

Smith, A ;

Zhang, B ;

Lin, S ;

Despres, N ;

Wu, AHB ;

Bluestein, BI .

CLINICA CHIMICA ACTA, 2004, 340 (1-2) :163-172

[5] The STARD statement for reporting studies of diagnostic accuracy: Explanation and elaboration [J].

Bossuyt, PM ;

Reitsma, JB ;

Bruns, DE ;

Gatsonis, CA ;

Glasziou, PP ;

Irwig, LM ;

Moher, D ;

Rennie, D ;

de Vet, HCW ;

Lijmer, JG .

CLINICAL CHEMISTRY, 2003, 49 (01) :7-18

[6] Dilpeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form [J].

Brandt, I ;

Lambeir, AM ;

Ketelslegers, JM ;

Vanderheyden, M ;

Scharpé, S ;

De Meester, I .

CLINICAL CHEMISTRY, 2006, 52 (01) :82-87

[7] High intraindividual variation of B-type natriuretic peptide (BNP) and amino-terminal proBNP in patients with stable chronic heart failure [J].

Bruins, S ;

Fokkema, MR ;

Römer, JWP ;

DeJongste, MJL ;

Van der Dijs, FPL ;

Van den Ouewland, JMW ;

Muskiet, FAJ .

CLINICAL CHEMISTRY, 2004, 50 (11) :2052-2058

[8] Associations among androgpens, estrogems, and natriuretic peptides in young women - Observations from the Dallas Heart Study [J].

Chang, Alice Y. ;

Abdullah, Shuaib M. ;

Jain, Tulika ;

Stanek, Harold G. ;

Das, Sandeep R. ;

McGuire, Darren K. ;

Auchus, Richard J. ;

de Lemos, James A. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 49 (01) :109-116

[9] Is nesiritide really that good or that bad? - Response to letter to the editor by Cheng [J].

Fitzgerald, RL ;

Maisel, A ;

Bhalla, V .

AMERICAN HEART JOURNAL, 2006, 151 (04)

[10] Reference change values for brain natriuretic peptides revisited [J].

Fokkema, M. Rebecca ;

Herrmann, Zuzana ;

Muskiet, Frits A. J. ;

Moecks, Joachim .

CLINICAL CHEMISTRY, 2006, 52 (08) :1602-1603

← 1 2 3 →